These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Cell kinetic studies of the cytostatic and cytocidal effect of 1-beta-D-arabinofuranosylcytosine on the L1210 ascites tumor.
    Author: Fietkau R, Friede H, Maurer-Schultze B.
    Journal: Cancer Res; 1984 Mar; 44(3):1105-13. PubMed ID: 6692397.
    Abstract:
    The effect of 1-beta-D-arabinofuranosylcytosine (ara-C) on mouse L1210 ascites tumor cells was studied in vivo with cell kinetic methods. Injection of ara-C (200 mg/kg) leads to an immediate inhibition of DNA synthesis and, thus, to a block of G1 cells at the G1-S border. This dose of ara-C kills a considerable fraction (at least 54%) of the L1210 cells. A double-labeling experiment with [3H]thymidine and [14C]thymidine which permits the distinction of cells in different cycle phases shows that ara-C kills the majority of cells in S phase, while only a minor fraction of G1 cells are lethally damaged. A multicompartment model is utilized to derive from the results of the double-labeling experiment the rates of cell loss out of the different cycle phases. Eighty-seven percent of the cells that are in S phase at the time of ara-C application and 21% of the cells in G1 are killed by ara-C. The repopulation of the tumor starts from the remaining G1 cells. A mean life span of the necrotic cells of 1.9 hr is derived from the model.
    [Abstract] [Full Text] [Related] [New Search]